Speaker 1: Global business news twenty four hours a day at Bloomberg
Speaker 1: dot Com, the radio plus mobile lap and on your radio.
Speaker 1: This is a Bloomberg Business flag from Bloomberg World Handquarters.
Speaker 1: I'm Charlie Pellett. Now a down day for both the
Speaker 1: down Jones Industrial Average and the SMP five hundred index.
Speaker 1: The SMP hovering out a record now at twenty one
Speaker 1: seventy nine, down a point and a half. That's drop
Speaker 1: of about point one percent. Down. Industrial is also down
Speaker 1: by point one percent, falling sixteen points to eighteen thousand,
Speaker 1: five hundred twelve. Naz Dak holding onto a game, up
Speaker 1: eight points to fifty two twenty one. If you're keeping
Speaker 1: track record on naz danc fifty two twenty eight point
Speaker 1: seventy one, a gain right now with two tens of
Speaker 1: one percent, ten year up fifteen thirty seconds, had healed
Speaker 1: one point five four percent, and gold hired by six
Speaker 1: forty the ounce of five tens of one percent to
Speaker 1: thirteen forty two. I'm Charlie Pellett, and that's a Bloomberg
Speaker 1: Business flash. This is taking stock with pin Box and
Speaker 1: Kathleen Hayes on Bloomberg Radio. The shares of Valiant of
Speaker 1: Pharmaceuticals hired right Now by more than twenty percent, even
Speaker 1: though it posted a wider loss in its latest quarter.
Speaker 1: But the company says it's going to reorganize and continuing
Speaker 1: to remake itself as a conventional pharmaceutical firm. Here to
Speaker 1: tell us more is Liz Kruda Hollow, Specialty Pharma and
Speaker 1: Biotech analyst for Bloomberg Intelligence, and you can follow Liz
Speaker 1: on Twitter at Liz Underscore Kruda Hollow. Liz, thanks very
Speaker 1: much for joining us. Tell us about Valiant Pharmaceuticals and
Speaker 1: why is the stock surging. Yeah, so most people were
Speaker 1: pretty happy to see that guidance have been maintained for
Speaker 1: the year. We were expecting to see potentially some color
Speaker 1: around whether or not they expect that they could still
Speaker 1: meet their guidance on revenue and EPs and ITTA, which
Speaker 1: they do say that they can do, despite the fact
Speaker 1: that to did not look all that promising on those metrics.
Speaker 1: Now that they have to reaffirm their guidance in order
Speaker 1: to manage the debt covenants that they have with their lenders. Yeah,
Speaker 1: so that's certainly part of it. So most of their
Speaker 1: debt covenants are tied to their EBITA ratios, and so
Speaker 1: that's something that we need to watch very carefully and
Speaker 1: make sure that they are maintained, otherwise the debt repayments
Speaker 1: could accelerate. So one of the interesting things that came
Speaker 1: up in the fault today was they have divested several
Speaker 1: small assets, nothing too large, but they did indicate that
Speaker 1: they've received interest on what could potentially be a larger deal,
Speaker 1: and that could be something that would be about two
Speaker 1: billion dollars in revenue but could get them an additional
Speaker 1: eight billion dollars for debt repayments. So that may be
Speaker 1: something that they look to to maintain that guidance, to
Speaker 1: make sure that they do actually meet the EBATA guidance
Speaker 1: and repay their debts for the year. The chief executive
Speaker 1: of Valiant, Joe Papa, is he going to remake this
Speaker 1: company me so that it looks nothing like the Valiant
Speaker 1: of big acquisitions and big price increases. So that's the
Speaker 1: goal here and that's certainly what we would like to
Speaker 1: see on That's what most investors are really looking for
Speaker 1: a complete turnaround in strategy, as it's clear that the
Speaker 1: strategy of growing simply through M and A and price
Speaker 1: increases really is no longer sustainable. So Papa comes from Parago,
Speaker 1: which is mostly age generic and consumer health company, so
Speaker 1: there are some synergies with the Valiant portfolio, and I
Speaker 1: think on the consumer health side he can do a
Speaker 1: really nice job with that. And he's done a pretty
Speaker 1: good job of leading a turnaround at Parago, So we're
Speaker 1: expecting that, you know, that's essentially why the board brought
Speaker 1: him on to take over from Pearson. Now, another stock
Speaker 1: in the pharmaceutical industry that is surging today is Endo
Speaker 1: International shares. They are higher by more than twenty one
Speaker 1: percent right now. Tell us about Endo. So Endo is
Speaker 1: an interesting company. Day are sort of on the fence
Speaker 1: in terms of whether or not they are generics company
Speaker 1: or a specialty company. They're quite divided. However, they made
Speaker 1: an acquisition of par Pharmaceuticals last year in September that
Speaker 1: puts them much more focused on the generic side. So
Speaker 1: basically in one queue we saw a huge impact on
Speaker 1: pricing and it was very detrimental to their earnings. They
Speaker 1: basically expect to see continuation of that erosion throughout the year.
Speaker 1: So we're expecting a bigger hit into q than we
Speaker 1: actually saw. So about some renewed enthusiasm there and that
Speaker 1: perhaps that one que was a one time effect and
Speaker 1: that it should moderate through the rest of the year.
Speaker 1: The company is still guiding tours that by percent decline
Speaker 1: each quarter, so that's something we need to keep an
Speaker 1: eye on and make sure that people don't get a
Speaker 1: little too enthusiastic about the surprise in two Q. Thank
Speaker 1: you very much for spending time with us. Liz Kruda
Speaker 1: Hollow is our specialty format and biotech analysts for blue
Speaker 1: Berg Intelligence. Of course, Bloomberg Intelligence providing unique and real
Speaker 1: time research and context in a variety of industries as
Speaker 1: well as markets and government factors that affect business. Our
Speaker 1: terminal customers can access this function at b I Go.
Speaker 1: We turn now to politics, and I'd like to bring
Speaker 1: in Mark Halpern. He is, of course the co author
Speaker 1: of the book Game Change and host of Bloomberg TVs
Speaker 1: with all due respect and it can be seen weekdays
Speaker 1: at five pm Eastern as well as week nights at
Speaker 1: five pm on Bloomberg in Washington, d C. Mark Halprin,
Speaker 1: thank you very much for being here. Let's begin by
Speaker 1: just reviewing the speech that Donald Trump made yesterday at
Speaker 1: the Detroit Economic Club. What has been the reaction to
Speaker 1: his economic proposals? Very favorable reaction from the Wall Street
Speaker 1: Journal editorial page, which is a pretty good arbiter of
Speaker 1: where it sort its mainstream center right thinking is they
Speaker 1: criticize his Paul sees on trade, which they disagree with,
Speaker 1: but they liked much of the rest of what he did.
Speaker 1: I don't think you saw very much what we call
Speaker 1: man by dog reaction, which is to say Democrats criticized
Speaker 1: the plan in seventeen different ways. I think Republicans were
Speaker 1: generally supportive, and a lot of Republicans pleased to see
Speaker 1: Trump talking about some of the orthodox positions the Republican Party,
Speaker 1: like tax cutting, less regulation, changing the Affordable Care Act.
Speaker 1: But some Republican senators not swayed by his speech on economics. Indeed,
Speaker 1: the GOP senator Susan Collins says she's not gonna be
Speaker 1: supporting Donald Trump. Can we expect more of this pretty
Speaker 1: big defection? And I do think it will lead to more.
Speaker 1: You know, Donald Trump will say, and I think he's
Speaker 1: quite right that you'd rather have Republican voters than Republican
Speaker 1: politicians at a time when Washington and political figures are
Speaker 1: not in particularly high regard. At the same time, Susan
Speaker 1: Collins is a very respected figure. She made her announcement
Speaker 1: that she wasn't going to vote for Trump in an
Speaker 1: opinion piece in The Washington Post in which he basically
Speaker 1: laid most of it off the questions about his temperament
Speaker 1: and judgment, particularly his conflict of recent conflict with the
Speaker 1: con Family. This is the exact argument that Hillary Clinton
Speaker 1: is making against Donald Trump is senator. Her argument is
Speaker 1: to have a respected figure in the Republican Party basically say,
Speaker 1: I agree with Hillary Clinton. Donald Trump doesn't have the
Speaker 1: right temperament to be president. It's pretty damning thing. And
Speaker 1: I do think Trump will almost certainly see more defections
Speaker 1: and some perhaps is a direct result of what Susan
Speaker 1: Collins has done. Alright, Susan Collins a Republican Senator from Maine.
Speaker 1: Third party candidates Mark Halprin Uh, whether it is the
Speaker 1: Libertarian Party, the Green Party, or a new entrant an
Speaker 1: independent candidate, Evan McMullen. It's going to be a guest
Speaker 1: on with all due respect today tell us about third
Speaker 1: party candidates, Well, it's very hard in this country that
Speaker 1: so favors the two major parties to break through at
Speaker 1: any level, particularly the presidential level, without fame and vast
Speaker 1: fortune or some pretty clear issue differences with the two
Speaker 1: major party candidates. You've now got a Green candidate, a
Speaker 1: Libertarian Candida, and now this independent candidate or Republican who's
Speaker 1: running after a day and make it pretty clear that
Speaker 1: he's opposed to both Hillary Clinton and Donald Trump. I
Speaker 1: think the the issue for all of them is can
Speaker 1: they get that virtuous cycle going in politics? You want
Speaker 1: to raise money, have people here about your raising money?
Speaker 1: Take you seriously. Your poll numbers go up, you get
Speaker 1: more media attention because people see the rising and the
Speaker 1: polls and raising money, and then off that media attention
Speaker 1: you raise more money and your poll numbers continue to
Speaker 1: go up. So can he get that virtuous cycle going?
Speaker 1: Can the Libertarians? Can the Green ideas matter? For sure?
Speaker 1: And all three of the all three of those parties
Speaker 1: are have fielded candidates who are clearly are looking to
Speaker 1: expand their uh their reach based on ideas, But but
Speaker 1: they need money, they need access to the media, they
Speaker 1: need to have the polls go up, and obviously all
Speaker 1: three of them would like to see their poll numbers
Speaker 1: go up high enough that they can get into the
Speaker 1: presidential debates. Does Evan McMullen have what it takes to
Speaker 1: get on the ballot in Utah to the point where
Speaker 1: he denies Donald Trump what has typically voted as a
Speaker 1: Republican state. Well, he's from Utah, he is a Mormon,
Speaker 1: and and and certainly as he looks at the states
Speaker 1: where he can do well, that'd be near at or
Speaker 1: near the top of the list. He says he's running
Speaker 1: to win and needs a lot more than just not
Speaker 1: just Utah, but perhaps other Western states with large Mormon populations.
Speaker 1: And he does have to solve the puzzle of how
Speaker 1: to get on the ballot. Even in states where the
Speaker 1: deadlines haven't passed, it's still a difficult task to gather
Speaker 1: the signatures and fulfill the other requirements. So Utah is
Speaker 1: certainly in intriguing possibility, but it's not the only state
Speaker 1: he plans to compete in. Just to pick up on
Speaker 1: what you just mentioned a moment ago about the presidential debates,
Speaker 1: what would it take for the libertarian candidate, let's say
Speaker 1: Gary Johnson or Green Party nominee Jill Stein, or indeed
Speaker 1: Evan McMullan to actually be at one of those lecterns
Speaker 1: in one of the three presidential debates, well the Commission
Speaker 1: Presidential Debates that said you need to be at fifteen
Speaker 1: percent in a series of national polls in order to qualify.
Speaker 1: Donald Trump has said has said again as recently It's
Speaker 1: Today to Time Magazine, that he wants to say in
Speaker 1: some of the dimensions of this of how the debates work,
Speaker 1: the anothering magic about the fifteen percent threshold. Trump has
Speaker 1: also said that he'd like one on one with Hillary Clint.
Speaker 1: He doesn't want other candidates on the stage, and I
Speaker 1: suspect that he will try to use his leverage, uh
Speaker 1: to extent he has any to make sure that other
Speaker 1: candidates aren't on the stage, assuming that he really does
Speaker 1: want that one on one that he says he does,
Speaker 1: if one of those third part of candidates does get
Speaker 1: on the stage, who does that help? Who does that hurt? Now?
Speaker 1: I've asked a lot of my best sources about that,
Speaker 1: and there's mixed feelings about it. I don't think there's
Speaker 1: any clear answer to it at this point. My guess
Speaker 1: is Trump probably is right that he's better off one
Speaker 1: on one simply because as he's behind and he needs
Speaker 1: to try to kind of get a clean shot at
Speaker 1: the person who's ahead of him. Now, thank you very much.
Speaker 1: Mark Halpern. He is, of course, co host of With
Speaker 1: All Due Respect, co managing editor of Bloomberg Politics, With
Speaker 1: all due Respect, weeknights five pm on Bloomberg Television and
Speaker 1: Bloomberg One in Washington, d C. This is Bloomberg